T HE U NIVERSITY OF N EW M EXICO ▪ H EALTH S CIENCES C ENTER. Exploratory IND Studies. Michael Briggs, Operations Director Human Research Protections [email protected] 272-1147. August 2006. Topics. General Overview of IND Types & Components Focus on “ Exploratory IND”
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
THE UNIVERSITYOF NEW MEXICO▪ HEALTH SCIENCES CENTER
Exploratory IND Studies
Michael Briggs, Operations Director
Human Research Protections
Clinical exploratory approach to enable sponsors to more efficiently identify and develop promising compounds under an IND, based on a more limited preclinical data set than that required for a traditional Phase 1 study.
Depending on type of study (3 examples)
Repeat Dose Toxicity (repeat dosing “ok” if separated by 1 week)
Not required for ExpIND
Note: Seek guidance from M.Briggs relating to GMP/GLP issues when planning IND study.